Welcome to CDC stacks | A Reader’s Guide to the Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline - 53156 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Reader’s Guide to the Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
Filetype[PDF-36.93 KB]


Details:
No Related Documents.
You May Also Like:
  1. Coming Soon
    A new era for treatment of drug-resistant tuberculosis
    Personal Author:
    Gandhi, Neel R.; Brust, James C.M.; Shah, N. Sarita;
    Published:
    October 04 2018
    Source:
    Eur Respir J. 52(4)
    Public Access
    Available on:
    October 04, 2019
  2. National Action Plan for Combating Multidrug-Resistant Tuberculosis : year two report May 2018
    Corporate Author:
    United States. Agency for International Development.. National Institute of Allergy and Infectious Diseases (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published:
    May 2018
    Description:
    NAP-MDR-TB-Year-Two-508.pdf
    File Type:
    Filetype[PDF - 617.78 KB]
  3. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis
    Personal Author:
    Mase, Sundari; Chorba, Terence; LoBue, Philip; Castro, Kenneth G.;
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
    Published:
    October 25, 2013
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-9
    Description:
    This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations, such as children, pregnant women, or persons with extrapulmonary MDR TB who were not included in the clinical t...
    Status:
    current
    File Type:
    Filetype[PDF - 420.66 KB]
  4. Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel
    Personal Author:
    Nachman, Sharon; Ahmed, Amina; Amanullah, Farhana; Becerra, Mercedes C; Botgros, Radu; Brigden, Grania; Browning, Renee; Gardiner, Elizabeth; Hafner, Richard; Hesseling, Anneke; How, Cleotilde; Jean-Philippe, Patrick; Lessem, Erica; Makhene, Mamodikoe; Mbelle, Nontombi; Marais, Ben; McIlleron, Helen; Mc Neeley, David F; Mendel, Carl; Murray, Stephen; Navarro, Eileen; Oramasionwu, Gloria E; Porcalla, Ariel R; Powell, Clydette; Powell, Mair; Rigaud, Mona; Rouzier, Vanessa; Samson, Pearl; Schaaf, H. Simon; Shah, Seema; Starke, Jeff; Swaminathan, Soumya; Wobudeya, Eric; Worrell, Carol;
    Published:
    May 06 2015
    Source:
    Lancet Infect Dis. 15(6):711-720.
    Description:
    Children younger than 18 years account for a substantial proportion of patients with tuberculosis worldwide. Available treatments for paediatric drug-susceptible and drug-resistant tuberculosis, albeit generally effective, are hampered by high pill b...
    File Type:
    Filetype[PDF - 1.10 MB]
  5. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
    Personal Author:
    Osman, Muhammad; Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Schaaf, H. Simon; Moore, Brittany K.; Hicks, Robert M.; Achar, Jay; Amanullah, Farhana; Barry, Pennan; Becerra, Mercedes; Chiotan, Domnica I.; Drobac, Peter C.; Flood, Jennifer; Furin, Jennifer; Gegia, Medea; Isaakidis, Petros; Mariandyshev, Andrei; Ozere, Iveta; Shah, N. Sarita; Skrahina, Alena; Yablokova, Elena; Seddon, James A.; Hesseling, Anneke C.;
    Corporate Author:
    for The Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB
    Published:
    Mar 2019
    Source:
    Emerg Infect Dis. 25(3):441-450
    Description:
    Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriol...
    File Type:
    Filetype[PDF - 961.79 KB]